BMS-584622

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBMS-584622

Drug Alias NameBMS-584622

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsFibroblast growth factor 2 inhibitorsVascular endothelial growth factor receptor 3 antagonists +[5]

TargetsVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 3Fibroblast growth factor 2 +[5]

Therapy Area/IndicationsVascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesBristol-Myers Squibb Company

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBristol-Myers Squibb Company

Active IndicationsN/A

Inactive IndicationsVascular Diseases

Other Information

ATC CodeN/A